Akola Surgicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 1.00 M
as on 12-12-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 12-12-2024
- Revenue -0.40%
(FY 2021)
- Profit 6.37%
(FY 2021)
- Ebitda 31.72%
(FY 2021)
- Net Worth 39.92%
(FY 2021)
- Total Assets 76.89%
(FY 2021)
About Akola Surgicals
The Corporate was formerly known as Parth Ispat Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.50 Cr.
Parag Rajnikant, Ashish Dehankar, Sachin Mahajan, and One other member serve as directors at the Company.
- CIN/LLPIN
U27100MH2005PTC151843
- Company No.
151843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Akola, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Akola Surgicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Dhole  | Managing Director | 20-Jun-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sachin Mahajan | Director | 20-Jun-2006 | Current |
| Parag Rajnikant | Director | 20-Jun-2006 | Current |
| Ashish Dehankar | Director | 20-Jun-2006 | Current |
Financial Performance of Akola Surgicals.
Akola Surgicals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.4% decrease. The company also saw a slight improvement in profitability, with a 6.37% increase in profit. The company's net worth Soared by an impressive increase of 39.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akola Surgicals?
In 2021, Akola Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gf Biotech Private LimitedActive 18 years 7 monthsParag Rajnikant, Ashish Dehankar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jun 2023 | ₹4.00 M | Open |
Others Creation Date: 26 Nov 2009 | ₹5.00 M | Open |
The Yavatmal Urban Co-Op Bank Ltd Creation Date: 11 Jun 2008 | ₹6.00 M | Open |
How Many Employees Work at Akola Surgicals?
Unlock and access historical data on people associated with Akola Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akola Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akola Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
